Literature DB >> 22822096

Red meat and poultry, cooking practices, genetic susceptibility and risk of prostate cancer: results from a multiethnic case-control study.

Amit D Joshi1, Román Corral, Chelsea Catsburg, Juan Pablo Lewinger, Jocelyn Koo, Esther M John, Sue A Ingles, Mariana C Stern.   

Abstract

Red meat, processed and unprocessed, has been considered a potential prostate cancer (PCA) risk factor; epidemiological evidence, however, is inconclusive. An association between meat intake and PCA may be due to potent chemical carcinogens that are generated when meats are cooked at high temperatures. We investigated the association between red meat and poultry intake and localized and advanced PCA taking into account cooking practices and polymorphisms in enzymes that metabolize carcinogens that accumulate in cooked meats. We analyzed data for 1096 controls, 717 localized and 1140 advanced cases from the California Collaborative Prostate Cancer Study, a multiethnic, population-based case-control study. We examined nutrient density-adjusted intake of red meat and poultry and tested for effect modification by 12 SNPs and 2 copy number variants in 10 carcinogen metabolism genes: GSTP1, PTGS2, CYP1A2, CYP2E1, EPHX1, CYP1B1, UGT1A6, NAT2, GSTM1 and GSTT1. We observed a positive association between risk of advanced PCA and high intake of red meat cooked at high temperatures (trend P = 0.026), cooked by pan-frying (trend P = 0.035), and cooked until well-done (trend P = 0.013). An inverse association was observed for baked poultry and advanced PCA risk (trend P = 0.023). A gene-by-diet interaction was observed between an SNP in the PTGS2 gene and the estimated levels of meat mutagens (interaction P = 0.008). Our results support a role for carcinogens that accumulate in meats cooked at high temperatures as potential PCA risk factors, and may support a role for heterocyclic amines (HCAs) in PCA etiology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22822096      PMCID: PMC3584966          DOI: 10.1093/carcin/bgs242

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.741


  63 in total

1.  Socioeconomic status and breast cancer incidence in California for different race/ethnic groups.

Authors:  K Yost; C Perkins; R Cohen; C Morris; W Wright
Journal:  Cancer Causes Control       Date:  2001-10       Impact factor: 2.506

2.  Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate.

Authors:  A Kirschenbaum; A P Klausner; R Lee; P Unger; S Yao; X H Liu; A C Levine
Journal:  Urology       Date:  2000-10-01       Impact factor: 2.649

3.  Effects of marinating on heterocyclic amine carcinogen formation in grilled chicken.

Authors:  C P Salmon; M G Knize; J S Felton
Journal:  Food Chem Toxicol       Date:  1997-05       Impact factor: 6.023

4.  Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response.

Authors:  Anastasia Papafili; Michael R Hill; David J Brull; Robin J McAnulty; Richard P Marshall; Steve E Humphries; Geoffrey J Laurent
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

Review 5.  Inflammation in prostate carcinogenesis.

Authors:  Angelo M De Marzo; Elizabeth A Platz; Siobhan Sutcliffe; Jianfeng Xu; Henrik Grönberg; Charles G Drake; Yasutomo Nakai; William B Isaacs; William G Nelson
Journal:  Nat Rev Cancer       Date:  2007-04       Impact factor: 60.716

6.  A prospective study of meat and meat mutagens and prostate cancer risk.

Authors:  Amanda J Cross; Ulrike Peters; Victoria A Kirsh; Gerald L Andriole; Douglas Reding; Richard B Hayes; Rashmi Sinha
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

7.  Intake of heterocyclic aromatic amines and the risk of prostate cancer in the EPIC-Heidelberg cohort.

Authors:  Anja Sander; Jakob Linseisen; Sabine Rohrmann
Journal:  Cancer Causes Control       Date:  2010-11-20       Impact factor: 2.506

8.  Red meat intake and cancer risk: a study in Italy.

Authors:  A Tavani; C La Vecchia; S Gallus; P Lagiou; D Trichopoulos; F Levi; E Negri
Journal:  Int J Cancer       Date:  2000-05-01       Impact factor: 7.396

Review 9.  Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons.

Authors:  Aramandla Ramesh; Stormy A Walker; Darryl B Hood; Maria D Guillén; Klaus Schneider; Eric H Weyand
Journal:  Int J Toxicol       Date:  2004       Impact factor: 2.032

Review 10.  Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research.

Authors:  D W Layton; K T Bogen; M G Knize; F T Hatch; V M Johnson; J S Felton
Journal:  Carcinogenesis       Date:  1995-01       Impact factor: 4.944

View more
  36 in total

1.  Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies.

Authors:  Kana Wu; Donna Spiegelman; Tao Hou; Demetrius Albanes; Naomi E Allen; Sonja I Berndt; Piet A van den Brandt; Graham G Giles; Edward Giovannucci; R Alexandra Goldbohm; Gary G Goodman; Phyllis J Goodman; Niclas Håkansson; Manami Inoue; Timothy J Key; Laurence N Kolonel; Satu Männistö; Marjorie L McCullough; Marian L Neuhouser; Yikyung Park; Elizabeth A Platz; Jeannette M Schenk; Rashmi Sinha; Meir J Stampfer; Victoria L Stevens; Shoichiro Tsugane; Kala Visvanathan; Lynne R Wilkens; Alicja Wolk; Regina G Ziegler; Stephanie A Smith-Warner
Journal:  Int J Cancer       Date:  2016-05-15       Impact factor: 7.396

2.  Highlights From the Institute for Functional Medicine's 2014 Annual Conference: Functional Perspectives on Food and Nutrition: The Ultimate Upstream Medicine.

Authors:  Lara Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2014-10

Review 3.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

Review 4.  The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis.

Authors:  Josiah Ochieng; Gladys N Nangami; Olugbemiga Ogunkua; Isabelle R Miousse; Igor Koturbash; Valerie Odero-Marah; Lisa J McCawley; Pratima Nangia-Makker; Nuzhat Ahmed; Yunus Luqmani; Zhenbang Chen; Silvana Papagerakis; Gregory T Wolf; Chenfang Dong; Binhua P Zhou; Dustin G Brown; Anna Maria Colacci; Roslida A Hamid; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Amedeo Amedei; Rabeah Al-Temaimi; Fahd Al-Mulla; William H Bisson; Sakina E Eltom
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

5.  LHRH and LHR genotypes and prostate cancer incidence and survival.

Authors:  Sue Ann Ingles; Stephen V Liu; Jacek Pinski
Journal:  Int J Mol Epidemiol Genet       Date:  2013-11-28

6.  Consumption of deep-fried foods and risk of prostate cancer.

Authors:  Marni Stott-Miller; Marian L Neuhouser; Janet L Stanford
Journal:  Prostate       Date:  2013-01-17       Impact factor: 4.104

7.  Intake of Meat Mutagens and Risk of Prostate Cancer in a Cohort of U.S. Health Professionals.

Authors:  Sabine Rohrmann; Katharina Nimptsch; Rashmi Sinha; Walter C Willett; Edward L Giovannucci; Elizabeth A Platz; Kana Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-07-29       Impact factor: 4.254

Review 8.  Endocrine-disrupting chemicals and skin manifestations.

Authors:  Qiang Ju; Christos C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

Review 9.  Dietary factors and risk for advanced prostate cancer.

Authors:  Wambui G Gathirua-Mwangi; Jianjun Zhang
Journal:  Eur J Cancer Prev       Date:  2014-03       Impact factor: 2.497

10.  Cytochrome P450 2E1 RsaI/PstI polymorphism is associated with urologic cancer risk: evidence from a meta-analysis.

Authors:  You-Cheng Lin; Xun Wu; Xue-Qiong Zhou; Rui Ren; Ze-Xuan Su; Chun-Xiao Liu
Journal:  Int J Clin Exp Med       Date:  2015-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.